These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4911086)

  • 1. [Pharmacology of bezitramide].
    Knape H
    Ned Tijdschr Geneeskd; 1970 May; 114(21):896-7. PubMed ID: 4911086
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of pain with bezitramide].
    Zegveld C
    Ned Tijdschr Geneeskd; 1970 May; 114(21):897-900. PubMed ID: 5446488
    [No Abstract]   [Full Text] [Related]  

  • 3. Bezitramide (R 4845), a new potent and orally long-acting analgesic compound.
    Janssen PA; Niemegeers CJ; Schellekens KH; Marsboom RH; Herin VV; Amery WK; Admiraal PV; Bosker JT; Crul JF; Pearce C; Zegveld C
    Arzneimittelforschung; 1971 Jun; 21(6):862-7. PubMed ID: 5109278
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of strong oral analgesics: the relief of postoperative pain using dextromoramide, pentazocine and bezitramide.
    Kay B
    Br J Anaesth; 1973 Jun; 45(6):623-8. PubMed ID: 4577940
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of chronic pain syndromes with bezitramide].
    Knape H
    Anaesthesist; 1972 Jun; 21(6):251-4. PubMed ID: 5049437
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical pharmacology of Lilly compound LY150720, a unique 4-phenylpiperidine analgesic.
    Hynes MD; Smits SE; Cantrell BE; Nickander R; Zimmerman DM
    NIDA Res Monogr; 1982 Apr; 41():119-25. PubMed ID: 6289112
    [No Abstract]   [Full Text] [Related]  

  • 7. Further experiences with bezitramide. Its analgesic action and side effects in patients operated upon for lumbar disc protrusion.
    Knape H
    Br J Anaesth; 1971 Jan; 43(1):76-83. PubMed ID: 4929252
    [No Abstract]   [Full Text] [Related]  

  • 8. Central nervous system depressant, analgesic and monoamine oxidase inhibitory properties of substituted piperidines.
    Pandey BR; Agrawal DK; Parmar SS; Willson WW; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):173-6. PubMed ID: 6701401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pharmacology and therapeutic results of a specific antagonist in disorders of gastroduodenal and peripheral motility].
    Bertrand J; Thillier JL
    Sem Hop; 1980 Oct 18-25; 56(39-40):1579-81. PubMed ID: 6255572
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Pharmacological studies on centrally-acting drugs belonging to enaminone mannich bases. II. Pharmacology of MK l-203 and l-907, new potent analgesics.
    Káse Y; Saita M; Takahama K; Masaki K; Miyata T
    Jpn J Pharmacol; 1974; 24(0):s:86. PubMed ID: 4545973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacology of dimethylaminoethyl ester of diphenylethoxyacetic acid hydrochloride--estocin].
    Kingisepp GIa; Kurvits KhKh; Nurmand LB
    Farmakol Toksikol; 1969; 32(6):710-2. PubMed ID: 5381602
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
    Wiese C; Grosse Maestrup E; Schepmann D; Vela JM; Holenz J; Buschmann H; Wünsch B
    J Pharm Pharmacol; 2009 May; 61(5):631-40. PubMed ID: 19406002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroral management of chronic pain by means of bezitramide (R 4845), a long-acting analgesic, and droperidol (R 4749), a neuroleptic. A multicentric pilot-study.
    Amery WK; Admiraal PV; Beck PH; Bosker JT; Crul JF; Feikema JJ; Knape H; Kuippers T; Lampe CF; van Mansvelt J; Pearce C; Pel JW; van Schaick CD; Schneider JH; van Vark-Berends JA; Zegveld C
    Arzneimittelforschung; 1971 Jun; 21(6):868-71. PubMed ID: 5109279
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with bezitramide and droperidol in the treatment of severe chronic pain.
    Admiraal PV; Knape H; Zegveld C
    Br J Anaesth; 1972 Nov; 44(11):1191-6. PubMed ID: 4119073
    [No Abstract]   [Full Text] [Related]  

  • 15. Antinociceptive activity of coniine in mice.
    Arihan O; Boz M; Iskit AB; Ilhan M
    J Ethnopharmacol; 2009 Sep; 125(2):274-8. PubMed ID: 19580858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of antalgic drugs].
    Dubray C
    Therapie; 1999; 54(1):135-45. PubMed ID: 10216437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experiences with bezitramide (R 4845), a potent orally long-acting analgesic.
    Vaerenberg C
    Acta Clin Belg; 1971; 26(1):11-20. PubMed ID: 5151178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of psychoexperimental performance under the effect of the analgesic propiramfumarate].
    Doenicke A; Feist HW; Kugler J
    Arzneimittelforschung; 1974 Apr; 24(4):693-6. PubMed ID: 4599303
    [No Abstract]   [Full Text] [Related]  

  • 20. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
    Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R
    J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.